Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index

LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

Prior Day Closing Value7760.064710.18
Prior Day Change %+1.15%+0.09%
Current Value
Current Day Change %+0.21%-0.01%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Apr 01, 2017)

No. of Constituents 34
Total Market Cap ($ in millions) 570,920
Mean Market Cap ($ in millions) 16,792
Median Market Cap ($ in millions) 3,465
Largest Constituent ($ in millions) 121,040
Smallest Constituent ($ in millions) 356

Market Cap Breakdown (Apr 01, 2017)

Top 10 Constituents (Apr 01, 2017)

Constituent Ticker Weight
Nektar Therapeutics NKTR 5.30%
Omeros Corp OMER 4.03%
Vertex Pharmaceuticals Inc VRTX 3.84%
Acadia Pharmaceuticals Inc ACAD 3.79%
Medicines Co/the MDCO 3.67%
Exelixis Inc EXEL 3.65%
Incyte Corp INCY 3.59%
Theravance Biopharma Inc TBPH 3.27%
Tesaro Inc TSRO 3.27%
Halozyme Therapeutics Inc HALO 3.24%
Data Updated Monthly
Download All Constituents